Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Drug pricing

Public call for Roche to cut price of breast cancer drug

Roche petitioned to lower £90,000 breast cancer drug Kadcyla in order to make it available to the NHS

Source: Roche

Roche is under pressure to reduce the cost of its breast cancer drug Kadcyla

An online petition calls on the drug company Roche to lower the price of its breast cancer drug Kadcyla (trastuzumab emtansine) to make it cheap enough to be made available on the NHS.

Almost 29,000 people have signed the petition, launched by breast cancer survivor Margaret Connolly whose niece Helen Mulhearn died from the disease.

The drug’s full list price of £90,000 per patient was deemed prohibitive by the National Institute for Health and Care Excellence (NICE). It made a draft decision in August 2014 not to make the drug available on the NHS on the grounds of cost. NICE said the cost would need to be cut by 60% to make it viable.

Trastuzumab emtansine targets breast cancer in two ways — by blocking cancer cell growth and destroying cells from within after penetrating their surface. There is evidence of patient benefit in terms of avoidance of side effects and extension of life. Although not available on the NHS, it can be accessed in England through the Cancer Drugs Fund.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066917

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.